SHARE-BASED COMPENSATION (SARS Activity) (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)	12 Months Ended
	Feb. 01, 2020	Feb. 02, 2019
Number of Underlying Shares Outstanding [Roll Forward]
Number of Underlying Shares, Outstanding (in shares)	796,725	1,041,867
Number of Underlying Shares, Granted (in shares)	0
Number of Underlying Shares, Exercised (in shares)	(43,463)
Number of Underlying Shares, Forfeited or expired (in shares)	(201,679)
Weighted-Average Exercise Price [Roll Forward]
Weighted-Average Exercise Price, Outstanding (in dollars per share)	$ 40.06	$ 37.81
Weighted-Average Grant Date Fair Value, Granted (in dollars per share)	0
Weighted-Average Exercise Price, Exercised (in dollars per share)	22.41
Weighted-Average Exercise Price, Forfeited or exercised (in dollars per share)	$ 32.27
Aggregate Intrinsic Value, Outstanding	$ 0
Weighted-Average Remaining Contractual Life, Outstanding	2 years 3 months 18 days
Number of Underlying Shares, Stock appreciation rights exercisable (in shares)	796,725
Weighted-Average Exercise Price, Stock appreciation rights exercisable (in dollars per share)	$ 40.06
Aggregate Intrinsic Value, Stock appreciation rights exercisable	$ 0
Weighted- Average Remaining Contractual Life, Stock appreciation rights exercisable	2 years 3 months 18 days
Number of Underlying Shares, Stock appreciation rights expected to become exercisable (in shares)	0
Weighted-Average Exercise Price, Stock appreciation rights expected to become exercisable (in dollars per share)	$ 0
Aggregate Intrinsic Value, Stock appreciation rights expected to become exercisable	$ 0
Weighted-Average Remaining Contractual Life, Stock appreciation rights expected to become exercisable	0 years